EnKash- Corporate Spend Management & Cards Platform
India
- Mumbai, MH
- 04/04/2022
- Series B
- $20,000,000
EnKash- Corporate Cards & Payments Platform
India's 1st, an all-in-one comprehensive corporate cards & payments platform.
We are on a mission to help businesses to optimise their cashflows & spends. EnKash offers range of corporate cards from managing purchases like supplier/ utility/ tax payments, expenses like travel & entertainment or digital marketing or cloud payments to payroll & petty cash to employee benefits like meal vouchers to gift cards for partners. EnKash enables businesses- big or small, to avail corporate cards to streamline their money movement.
EnKash's full-stack financial platform comes as a unique offering to provide much desired SAVINGS, VISIBILITY & CONTROL. Now, businesses can manage all their business spends on cards with EnKash’s DIY platform. We offer extensive products suite to help businesses manage their payable, collection & expenses in the most seamless & secured way.
- Industry Financial Services
- Website https://www.enkash.com/
- LinkedIn https://www.linkedin.com/company/enkashbusiness/
Related People
Hemant VishnoiFounder
India -
Delhi,
- An entrepreneur, leading change now in B2B space
- Building one of finest startups, growing up fast
- Professional journey kick started with a start up
- Corporate experience with top rated organisations
- Built stupendous growth for businesses undertaken
- Amongst few who started early in digital payments & still loving it
Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)